PRPH: ProPhase Labs, Inc. Stock

by  •  • Comments Off on PRPH: ProPhase Labs, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14.24
Enterprise Value ($M) 28.42
Book Value ($M) 7.35
Book Value / Share 0.18
Price / Book 1.94
NCAV ($M) -25.21
NCAV / Share -0.60
Price / NCAV -0.56

Profitability (mra)
Return on Invested Capital (ROIC) -1.67
Return on Assets (ROA) -0.59
Return on Equity (ROE) -1.19

Liquidity (mrq)
Quick Ratio 0.92
Current Ratio 0.95

Balance Sheet (mrq) ($M)
Current Assets 30.64
Assets 63.20
Liabilities 55.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.77
Operating Income -38.63
Net Income -53.36
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -17.54
Cash from Investing 2.42
Cash from Financing 14.19

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A
2025-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 208,233 957,382 21.75
2025-05-12 74,943 552,956 13.55
2025-05-09 330,124 1,064,478 31.01
2025-05-08 114,062 587,918 19.40

(click for more detail)

Similar Companies
PMN – ProMIS Neurosciences, Inc. PRFX – PainReform Ltd.
PROK – ProKidney Corp. PRQR – ProQR Therapeutics N.V.
PRTG – Portage Biotech Inc.


Financial data and stock pages provided by
Fintel.io